Sunobinop shows promising efficacy in interstitial cystitis bladder pain syndrome Urology Times The Model of Interstitial Cystitis for Evaluating New Molecular Strategies of Interstitial Regeneration in Humans BPC 157 is back in the conversation as a potential peptide to improve musculoskeletal tissue repair. One registered Phase 1 trial in healthy volunteers exists for an oral formulation (NCT02637284) Brandon Roberts Frontiers Identification and validation of immune and diagnostic biomarkers for interstitial cystitis painful bladder syndrome by integrating bioinformatics and machine learning Interstitial Cystitis Bladder Pain Syndrome Patient Phenotyping Wolff 2026 Neurourology and Urodynamics Wiley Online Library Multi omics analysis identifies a microbiotabile acidTLR signaling axis driving bladder injury in interstitial cystitis Nature Communications